Human Metabolome Technologies, Inc. (TYO:6090)
600.00
-23.00 (-3.69%)
Jun 4, 2026, 3:30 PM JST
TYO:6090 Balance Sheet
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 1,456 | 1,562 | 1,788 | 1,656 | 1,504 | 1,245 |
Cash & Short-Term Investments | 1,456 | 1,562 | 1,788 | 1,656 | 1,504 | 1,245 |
Cash Growth | -11.44% | -12.64% | 7.97% | 10.11% | 20.80% | 2.13% |
Receivables | 290 | 171 | 228 | 129 | 158 | 148 |
Inventory | 50 | 51 | 36 | 26 | 43 | 34 |
Other Current Assets | 32 | 80 | 43 | 37 | 36 | 29 |
Total Current Assets | 1,828 | 1,864 | 2,095 | 1,848 | 1,741 | 1,456 |
Property, Plant & Equipment | 249 | 284 | 331 | 270 | 243 | 127 |
Long-Term Investments | 55 | 55 | 12 | 14 | 13 | 6 |
Other Intangible Assets | 22 | 12 | 17 | 21 | 6 | 4 |
Long-Term Deferred Tax Assets | 132 | 157 | 146 | 136 | 64 | 28 |
Other Long-Term Assets | 1 | 2 | 2 | 2 | 1 | 2 |
Total Assets | 2,287 | 2,374 | 2,603 | 2,291 | 2,068 | 1,623 |
Accounts Payable | 25 | 3 | 15 | - | - | - |
Accrued Expenses | 65 | 89 | 86 | 83 | 77 | 36 |
Short-Term Debt | 100 | 100 | 200 | 200 | 200 | 100 |
Current Portion of Leases | 1 | 7 | 14 | 13 | 9 | 19 |
Current Income Taxes Payable | 54 | 114 | 214 | 87 | 161 | 75 |
Other Current Liabilities | 141 | 136 | 103 | 110 | 99 | 87 |
Total Current Liabilities | 386 | 449 | 632 | 493 | 546 | 317 |
Long-Term Leases | 3 | 3 | 11 | 13 | 23 | 33 |
Other Long-Term Liabilities | 13 | 15 | 15 | 14 | 14 | 14 |
Total Liabilities | 402 | 467 | 658 | 520 | 583 | 364 |
Common Stock | 1,488 | 1,488 | 1,487 | 1,484 | 1,481 | 1,481 |
Additional Paid-In Capital | 7 | 7 | 6 | 3 | 1,470 | 1,470 |
Retained Earnings | 665 | 585 | 417 | 233 | -1,522 | -1,790 |
Treasury Stock | -257 | -166 | - | - | - | - |
Comprehensive Income & Other | -18 | -7 | 35 | 51 | 56 | 98 |
Shareholders' Equity | 1,885 | 1,907 | 1,945 | 1,771 | 1,485 | 1,259 |
Total Liabilities & Equity | 2,287 | 2,374 | 2,603 | 2,291 | 2,068 | 1,623 |
Total Debt | 104 | 110 | 225 | 226 | 232 | 152 |
Net Cash (Debt) | 1,352 | 1,452 | 1,563 | 1,430 | 1,272 | 1,093 |
Net Cash Growth | -5.46% | -7.10% | 9.30% | 12.42% | 16.38% | -8.99% |
Net Cash Per Share | 238.22 | 247.26 | 264.33 | 242.17 | 215.59 | 185.16 |
Filing Date Shares Outstanding | 5.61 | 5.68 | 5.92 | 5.91 | 5.9 | 5.9 |
Total Common Shares Outstanding | 5.61 | 5.69 | 5.92 | 5.91 | 5.9 | 5.9 |
Working Capital | 1,442 | 1,415 | 1,463 | 1,355 | 1,195 | 1,139 |
Book Value Per Share | 336.27 | 335.02 | 328.79 | 299.81 | 251.69 | 213.38 |
Tangible Book Value | 1,863 | 1,895 | 1,928 | 1,750 | 1,479 | 1,255 |
Tangible Book Value Per Share | 332.34 | 332.91 | 325.92 | 296.26 | 250.67 | 212.71 |
Order Backlog | - | 573.86 | 610.42 | 433.22 | 401.36 | 202.33 |